|
Volumn 42, Issue 2, 2006, Pages 253-260
|
Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate ABT-751, ABT-751 glucuronide, and ABT-751 sulfate in human plasma for clinical pharmacology studies
|
Author keywords
ABT 751; LC MS MS; Pharmacokinetics
|
Indexed keywords
A 93387;
ABT 751 GLUCURONIDE;
ABT 751 SULFATE;
ACETONITRILE;
AMMONIUM ACETATE;
BEVACIZUMAB;
CAPECITABINE;
DRUG METABOLITE;
FORMIC ACID;
IRINOTECAN;
N [2 [(4 HYDROXYPHENYL)AMINO] 3 PYRIDINYL] 4 METHOXYBENZENESULFONAMIDE;
SULFONAMIDE;
UNCLASSIFIED DRUG;
ACCURACY;
ARTICLE;
CALIBRATION;
CONTROLLED STUDY;
DILUTION;
DRUG BLOOD LEVEL;
EQUIPMENT;
FLOW RATE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
PRIORITY JOURNAL;
TANDEM MASS SPECTROMETRY;
VALIDATION PROCESS;
ANTIMITOTIC AGENTS;
CALIBRATION;
CHROMATOGRAPHY, LIQUID;
CLINICAL CHEMISTRY TESTS;
HUMANS;
MOLECULAR STRUCTURE;
REFERENCE STANDARDS;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
SULFONAMIDES;
TANDEM MASS SPECTROMETRY;
|
EID: 33747808956
PISSN: 07317085
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jpba.2006.04.010 Document Type: Article |
Times cited : (6)
|
References (8)
|